Phibro Animal Health Stock Price, Forecast & Analysis (NASDAQ:PAHC)

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

Phibro Animal Health announced a quarterly dividend on Monday, November 4th. Shareholders of record on Wednesday, November 27th will be paid a dividend of $0.12 per share on Wednesday, December 18th. This represents a $0.48 dividend on an annualized basis and a yield of 2.10%. The ex-dividend date is Tuesday, November 26th. View Phibro Animal Health's Dividend History.

Phibro Animal Health Corp (NASDAQ:PAHC) issued its quarterly earnings data on Monday, November, 4th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.24 by $0.05. The company had revenue of $190 million for the quarter, compared to analyst estimates of $199.22 million. Phibro Animal Health had a return on equity of 25.52% and a net margin of 4.99%. Phibro Animal Health's revenue was down 5.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.39 earnings per share. View Phibro Animal Health's Earnings History.

Phibro Animal Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Phibro Animal Health.

Phibro Animal Health updated its FY20 earnings guidance on Monday, November, 4th. The company provided EPS guidance of $1.08-$1.14 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.12.

5 brokers have issued 12 month target prices for Phibro Animal Health's stock. Their forecasts range from $18.00 to $42.00. On average, they anticipate Phibro Animal Health's share price to reach $26.60 in the next year. This suggests a possible upside of 16.1% from the stock's current price. View Analyst Price Targets for Phibro Animal Health.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 2 sell ratings, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Phibro Animal Health.

Media headlines about PAHC stock have trended very negative recently, according to InfoTrie. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Phibro Animal Health earned a news impact score of -3.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Phibro Animal Health.

Phibro Animal Health saw a decrease in short interest in the month of September. As of September 30th, there was short interest totalling 623,400 shares, a decrease of 5.9% from the August 30th total of 662,400 shares. Based on an average trading volume of 225,000 shares, the days-to-cover ratio is currently 2.8 days. Currently, 3.1% of the company's stock are sold short. View Phibro Animal Health's Current Options Chain.

Some companies that are related to Phibro Animal Health include FibroGen (FGEN), Blueprint Medicines (BPMC), Evotec (EVTCY), Nektar Therapeutics (NKTR), Alkermes (ALKS), Allakos (ALLK), Emergent Biosolutions (EBS), Global Blood Therapeutics (GBT), Taro Pharmaceutical Industries (TARO), HUTCHISON CHINA/S (HCM), Genmab A/S (GMAB), BridgeBio Pharma (BBIO), Myokardia (MYOK), PTC Therapeutics (PTCT) and Biohaven Pharmaceutical (BHVN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Intercept Pharmaceuticals (ICPT), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Zoetis (ZTS), Booking (BKNG), Ophthotech (OPHT) and RetailMeNot (SALE).

Phibro Animal Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Chartwell Investment Partners LLC (0.73%), Eagle Asset Management Inc. (0.69%), Tocqueville Asset Management L.P. (0.68%), Confluence Investment Management LLC (0.36%), Mackay Shields LLC (0.33%) and SG Americas Securities LLC (0.21%). Company insiders that own Phibro Animal Health stock include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras, E Thomas Corcoran, Jack Bendheim and Larry Lee Miller. View Institutional Ownership Trends for Phibro Animal Health.

PAHC stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc. and Dupont Capital Management Corp. Company insiders that have sold Phibro Animal Health company stock in the last year include Daniel M Bendheim and Dean J Warras. View Insider Buying and Selling for Phibro Animal Health.

PAHC stock was acquired by a variety of institutional investors in the last quarter, including Tocqueville Asset Management L.P., Chartwell Investment Partners LLC, SG Americas Securities LLC, First Trust Advisors LP, Russell Investments Group Ltd., Oppenheimer Asset Management Inc., Mackay Shields LLC and Bridge City Capital LLC. View Insider Buying and Selling for Phibro Animal Health.

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PAHC stock can currently be purchased for approximately $22.91.

Phibro Animal Health has a market capitalization of $926.78 million and generates $828 million in revenue each year. The company earns $54.71 million in net income (profit) each year or $1.53 on an earnings per share basis. Phibro Animal Health employs 1,600 workers across the globe.View Additional Information About Phibro Animal Health.

The official website for Phibro Animal Health is http://www.pahc.com/.

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]